Reply: Triggering Stent Optimization by Coronary Physiology

Free article

Comment

Tara Neleman et al. JACC Cardiovasc Interv. 2022.

Free article

. 2022 Nov 14;15(21):2229-2230.

doi: 10.1016/j.jcin.2022.09.040.

No abstract available

Comment on

FFR-Guided PCI Optimization Directed by High-Definition IVUS Versus Standard of Care: The FFR REACT Trial.
Neleman T, van Zandvoort LJC, Tovar Forero MN, Masdjedi K, Ligthart JMR, Witberg KT, Groenland FTW, Cummins P, Lenzen MJ, Boersma E, Nuis RJ, den Dekker WK, Diletti R, Wilschut J, Zijlstra F, Van Mieghem NM, Daemen J. Neleman T, et al. JACC Cardiovasc Interv. 2022 Aug 22;15(16):1595-1607. doi: 10.1016/j.jcin.2022.06.018. JACC Cardiovasc Interv. 2022. PMID: 35981832 Clinical Trial.
Influence of Diffuse Disease on PCI Optimization: Don't Forget to Pull Back.
van Nunen LX, Collet C. van Nunen LX, et al. JACC Cardiovasc Interv. 2022 Nov 14;15(21):2228-2229. doi: 10.1016/j.jcin.2022.09.009. JACC Cardiovasc Interv. 2022. PMID: 36357029 No abstract available.
Triggering Stent Optimization by Coronary Physiology.
Munhoz D, Sakai K, Collet C, Mizukami T. Munhoz D, et al. JACC Cardiovasc Interv. 2022 Nov 14;15(21):2228. doi: 10.1016/j.jcin.2022.09.010. JACC Cardiovasc Interv. 2022. PMID: 36357030 No abstract available.